These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 37498360)

  • 1. Identification of variants in genes associated with hypertrophic cardiomyopathy in Mexican patients.
    García-Vielma C; Lazalde-Córdova LG; Arzola-Hernández JC; González-Aceves EN; López-Zertuche H; Guzmán-Delgado NE; González-Salazar F
    Mol Genet Genomics; 2023 Nov; 298(6):1289-1299. PubMed ID: 37498360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of variants in MYH7, MYBPC3 and TNNT2 with sudden cardiac death-related risk factors in Brazilian patients with hypertrophic cardiomyopathy.
    Mori AA; Castro LR; Bortolin RH; Bastos GM; Oliveira VF; Ferreira GM; Hirata TDC; Fajardo CM; Sampaio MF; Moreira DAR; Pachón-Mateos JC; Correia EB; Sousa AGMR; Brión M; Carracedo A; Hirata RDC; Hirata MH
    Forensic Sci Int Genet; 2021 May; 52():102478. PubMed ID: 33588347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic MYH7, MYBPC3, TPM1, TNNT2 and TNNI3 mutations in sporadic hypertrophic cardiomyopathy.
    Núñez L; Gimeno-Blanes JR; Rodríguez-García MI; Monserrat L; Zorio E; Coats C; McGregor CG; Hernandez del Rincón JP; Castro-Beiras A; Hermida-Prieto M
    Circ J; 2013; 77(9):2358-65. PubMed ID: 23782526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectrum of Mutations in Hypertrophic Cardiomyopathy Genes Among Tunisian Patients.
    Jaafar N; Gómez J; Kammoun I; Zairi I; Amara WB; Kachboura S; Kraiem S; Hammami M; Iglesias S; Alonso B; Coto E
    Genet Test Mol Biomarkers; 2016 Nov; 20(11):674-679. PubMed ID: 27574918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additional value of screening for minor genes and copy number variants in hypertrophic cardiomyopathy.
    Mademont-Soler I; Mates J; Yotti R; Espinosa MA; Pérez-Serra A; Fernandez-Avila AI; Coll M; Méndez I; Iglesias A; Del Olmo B; Riuró H; Cuenca S; Allegue C; Campuzano O; Picó F; Ferrer-Costa C; Álvarez P; Castillo S; Garcia-Pavia P; Gonzalez-Lopez E; Padron-Barthe L; Díaz de Bustamante A; Darnaude MT; González-Hevia JI; Brugada J; Fernandez-Aviles F; Brugada R
    PLoS One; 2017; 12(8):e0181465. PubMed ID: 28771489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First identification of homozygous truncating CSRP3 variants in two unrelated cases with hypertrophic cardiomyopathy.
    Janin A; Bessière F; Chauveau S; Chevalier P; Millat G
    Gene; 2018 Nov; 676():110-116. PubMed ID: 30012424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarcomeric hypertrophic cardiomyopathy: genetic profile in a Portuguese population.
    Brito D; Miltenberger-Miltenyi G; Vale Pereira S; Silva D; Diogo AN; Madeira H
    Rev Port Cardiol; 2012 Sep; 31(9):577-87. PubMed ID: 22857948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sarcomeric gene variants among Indians with hypertrophic cardiomyopathy: A scoping review.
    Koshy L; Ganapathi S; Jeemon P; Madhuma M; Vysakh Y; Lakshmikanth LR; Harikrishnan S
    Indian J Med Res; 2023 Aug; 158(2):119-135. PubMed ID: 37787257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic basis and outcome in a nationwide study of Finnish patients with hypertrophic cardiomyopathy.
    Jääskeläinen P; Vangipurapu J; Raivo J; Kuulasmaa T; Heliö T; Aalto-Setälä K; Kaartinen M; Ilveskoski E; Vanninen S; Hämäläinen L; Melin J; Kokkonen J; Nieminen MS; ; Laakso M; Kuusisto J
    ESC Heart Fail; 2019 Apr; 6(2):436-445. PubMed ID: 30775854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives.
    Andersen PS; Havndrup O; Hougs L; Sørensen KM; Jensen M; Larsen LA; Hedley P; Thomsen AR; Moolman-Smook J; Christiansen M; Bundgaard H
    Hum Mutat; 2009 Mar; 30(3):363-70. PubMed ID: 19035361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening of the
    Gómez J; Lorca R; Reguero JR; Morís C; Martín M; Tranche S; Alonso B; Iglesias S; Alvarez V; Díaz-Molina B; Avanzas P; Coto E
    Circ Cardiovasc Genet; 2017 Apr; 10(2):. PubMed ID: 28356264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of mutations in symptomatic patients with hypertrophic cardiomyopathy in Taiwan.
    Chiou KR; Chu CT; Charng MJ
    J Cardiol; 2015 Mar; 65(3):250-6. PubMed ID: 25086479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A human MYBPC3 mutation appearing about 10 centuries ago results in a hypertrophic cardiomyopathy with delayed onset, moderate evolution but with a risk of sudden death.
    Teirlinck CH; Senni F; Malti RE; Majoor-Krakauer D; Fellmann F; Millat G; André-Fouët X; Pernot F; Stumpf M; Boutarin J; Bouvagnet P
    BMC Med Genet; 2012 Nov; 13():105. PubMed ID: 23140321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of Hypertrophic Cardiomyopathy Related Gene Mutations and Clinical Manifestations in Vietnamese Patients With Hypertrophic Cardiomyopathy.
    Tran Vu MT; Nguyen TV; Huynh NV; Nguyen Thai HT; Pham Nguyen V; Ho Huynh TD
    Circ J; 2019 Aug; 83(9):1908-1916. PubMed ID: 31308319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Studies of Hypertrophic Cardiomyopathy in Singaporeans Identify Variants in
    Pua CJ; Tham N; Chin CWL; Walsh R; Khor CC; Toepfer CN; Repetti GG; Garfinkel AC; Ewoldt JF; Cloonan P; Chen CS; Lim SQ; Cai J; Loo LY; Kong SC; Chiang CWK; Whiffin N; de Marvao A; Lio PM; Hii AA; Yang CX; Le TT; Bylstra Y; Lim WK; Teo JX; Padilha K; Silva GV; Pan B; Govind R; Buchan RJ; Barton PJR; Tan P; Foo R; Yip JWL; Wong RCC; Chan WX; Pereira AC; Tang HC; Jamuar SS; Ware JS; Seidman JG; Seidman CE; Cook SA
    Circ Genom Precis Med; 2020 Oct; 13(5):424-434. PubMed ID: 32815737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse events in families with hypertrophic or dilated cardiomyopathy and mutations in the MYBPC3 gene.
    Ehlermann P; Weichenhan D; Zehelein J; Steen H; Pribe R; Zeller R; Lehrke S; Zugck C; Ivandic BT; Katus HA
    BMC Med Genet; 2008 Oct; 9():95. PubMed ID: 18957093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A DNA resequencing array for pathogenic mutation detection in hypertrophic cardiomyopathy.
    Fokstuen S; Lyle R; Munoz A; Gehrig C; Lerch R; Perrot A; Osterziel KJ; Geier C; Beghetti M; Mach F; Sztajzel J; Sigwart U; Antonarakis SE; Blouin JL
    Hum Mutat; 2008 Jun; 29(6):879-85. PubMed ID: 18409188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations.
    Girolami F; Ho CY; Semsarian C; Baldi M; Will ML; Baldini K; Torricelli F; Yeates L; Cecchi F; Ackerman MJ; Olivotto I
    J Am Coll Cardiol; 2010 Apr; 55(14):1444-53. PubMed ID: 20359594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mutations in sarcomeric genes MYH7, MYBPC3, TNNT2, TNNI3, and TPM1 in patients with hypertrophic cardiomyopathy].
    García-Castro M; Coto E; Reguero JR; Berrazueta JR; Alvarez V; Alonso B; Sainz R; Martín M; Morís C
    Rev Esp Cardiol; 2009 Jan; 62(1):48-56. PubMed ID: 19150014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals.
    Sedaghat-Hamedani F; Kayvanpour E; Tugrul OF; Lai A; Amr A; Haas J; Proctor T; Ehlermann P; Jensen K; Katus HA; Meder B
    Clin Res Cardiol; 2018 Jan; 107(1):30-41. PubMed ID: 28840316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.